 An open follow up study of patients enrolled in the Phase 12 clinical trial of haematopoietic stem cell gene therapy for the Wiskott-Aldrich Syndrome and treated with autologous CD34 cells transduced with the w1.6_hWASP_WPRE VSVg lentiviral vector. 